H. Brunner-La Rocca
Recent publications
-
Mourmans, S. G. J., Achten, A., Weerts, J., Scheepers, M., Barandiarán Aizpurua, A., Henkens, M., Uszko-Lencer, N., Brunner-La Rocca, H.-P., Knackstedt, C., & van Empel, V. P. M. (2026). The diagnostic yield of an elaborate workup for comorbidities in a real-life heart failure with preserved ejection fraction outpatient population. European Journal of Preventive Cardiology, 33(2), 276-285. https://doi.org/10.1093/eurjpc/zwaf429More information about this publication
-
Gilani, K., Wei, W., Peters, C., Verket, M., Brunner-La Rocca, H.-P., Nicolis, E., Colombo, M., Marx-Schutt, K., Urovi, V., & Dumontier, M. (2026). CMEO: a metadata-centric ontology for clinical studies exploration and harmonization assessment. BMC Medical Informatics and Decision Making, 26(1), Article 8. https://doi.org/10.1186/s12911-025-03272-5More information about this publication
-
Herrmann, J. J., Van Berlo, R., Brunner-La Rocca, H.-P., Sanders-Van Wijk, S., Gommans, D. H. F., & Van Kimmenade, R. R. J. (2026). Fluid restriction in patients with heart failure: a systematic review. Heart. Advance online publication. https://doi.org/10.1136/heartjnl-2025-326784More information about this publication
-
Steiner, B., Neumann, A., Schwertfeger, M., Verket, M., Romero, I., Hurtado, C., Schiefel, V., McNulty, A., Sankarpandi, S., Gingele, A. J., Helms, T. M., Brunner-La Rocca, H.-P., Zippel-Schultz, B., & iCARE4CVD Consortium (2025). Patient-reported outcome and experience measures in cardiovascular disease: a scoping review as part of iCARE4CVD. Journal of patient-reported outcomes, 9(1), Article 141. https://doi.org/10.1186/s41687-025-00980-4More information about this publication
-
Weerts, J., Aizpurua, A. B., Patel, R. B., van de Bovenkamp, A. A., Amin, H., Sanders-van Wijk, S., Mourmans, S. G. J., Achten, A., Handoko, M. L., Bayes-Genis, A., Brunner-La Rocca, H.-P., Shah, S. J., Knackstedt, C., & van Empel, V. P. M. (2025). A simplified approach for diagnosing heart failure with preserved ejection fraction by assessing the left atrium and natriuretic peptides. European journal of heart failure, 27(12), 2897-2902. https://doi.org/10.1002/ejhf.3651More information about this publication
-
Gingele, A. J., Eurlings, C., Boyne, J. J., & Brunner-La Rocca, H.-P. (2025). Identifying patients' signs and symptoms to guide eHealth-directed diuretic therapy intensification in heart failure-Insights from the trial of intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF). Wiener Klinische Wochenschrift, 137(23-24), 774-777. https://doi.org/10.1007/s00508-025-02551-5More information about this publication
-
Malgie, J., Wilde, M. I., Koudstaal, S., Denham, R., da Fonseca, C. A., Swart, H. P., van Ofwegen, C. E. E., Yilmaz, A., Pisters, R., Linssen, G. C. M., Faber, N., van Heerebeek, L., van de Swaluw, J. E. C., de Boer, R. A., Brunner-La Rocca, H.-P., & Brugts, J. J. (2025). Real-life implementation of guideline-recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE-HF. European journal of heart failure, 27(12), 2735-2746. https://doi.org/10.1002/ejhf.70006More information about this publication
-
Sikking, M., Wiethoff, I., Henkens, M., Evers, S., Stroeks, S., Venner, M., Weerts, J., Brunner-la Rocca, H.-P., Knackstedt, C., van Empel, V., Michels, M., Heymans, S., Hiligsmann, M., & Verdonschot, J. (2025). High societal costs and reduced health-related quality of life in inflammatory and systemic immune disease-associated dilated cardiomyopathies. Quality of Life Research, 34(10), 2901-2910. https://doi.org/10.1007/s11136-025-04027-5More information about this publication
-
Gilani, K., Verket, M., Peters, C., Dumontier, M., Rocca, H. P. B. L., & Urovi, V. (2025). CDE-Mapper: Using retrieval-augmented language models for linking clinical data elements to controlled vocabularies. Computers in Biology and Medicine, 196, Article 110745. https://doi.org/10.1016/j.compbiomed.2025.110745More information about this publication
-
Slob, B. P. H., Postma, M. J., Weersma, M., Rocca, H.-P. B.-L., de Jong, L. A., & Boersma, C. (2025). Cost-Effectiveness of Empagliflozin in Patients with Chronic Heart Failure Irrespective of Left-Ventricle Ejection Fraction in the Netherlands. American journal of cardiovascular drugs : drugs, devices, and other interventions, 25(5), 715-726. https://doi.org/10.1007/s40256-025-00749-6More information about this publication